Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NvfiledCriticalJanssen Pharmaceutica Nv
Priority to HN1996000030ApriorityCriticalpatent/HN1996000030A/en
Publication of HN1996000030ApublicationCriticalpatent/HN1996000030A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se relaciona con el tratamiento de enfermedades infecciosas y m s particularmente, est relacionada con el uso de una mezcla itraconazol-secnidazol para el tratamiento de enfer- medades infecciosas en el aparato reproductor femenino.It is related to the treatment of infectious diseases and more particularly, it is related to the use of an itraconazole-secnidazole mixture for the treatment of infectious diseases in the female reproductive system.
HN1996000030A1996-06-141996-06-14
USE OF AN ITRACONAZOL-SECNIDAZOLE MIXTURE FOR THE TREATMENT OF INFECTIOUS DISEASES IN THE FEMALE REPRODUCTIVE SYSTEM.
HN1996000030A
(en)
Use of (S) -adenosyl-L-methionine (SAMe) and its physiologically compatible salts for the treatment of reperfusion injury triggered by temporal-focal ischemia